+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

EHA Junior Research Grant

European Hematology Association

The EHA Junior Research Grant is a type of EHA Research Grant. Successful applicants can receive €50,000 per year for three years.

Like all EHA Research Grants, it’s designed to support the future of hematology by helping talented junior researchers to:

Conduct basic or translational lab-based research
Gain valuable research and leadership experience
Move towards becoming group leaders
Advance their careers

Specific criteria for the EHA Junior Research Grant

Our Junior Research Grant is suitable for researchers who:

Are currently carrying out basic or translational lab-based research in hematology
Received a PhD or PharmD less than four years before the closing date listed above

If you received your PhD or PharmD outside of this timeframe, please check our policy on life events. If this policy applies to you, you can ask us to extend the period of eligibility.

AI Based Application Success Predictor

🎯 1. Membership & Institutional Endorsements

You must be an active EHA member or guest to apply 

Your home and host institutions must confirm support, including approval of the grant conditions and protected time for Physician Scientist applicants 

🧬 2. Career-Stage & Scheme Selection

Junior, Advanced, and Physician-Scientist Research Grants offer €50K–€80K/year for 3 years—choose based on post-PhD experience (4–8 years, or with life-event extension) .

Innovation Grants support translational and collaborative consortia (€300K total, ≥3 PIs from ≥3 countries, including at least one junior member and one from eligible Eastern European nation) .

Bilateral Collaborative and Kick-Off Grants offer targeted funding for early-stage hypothesis-driven projects and international lab pairings .

🧠 3. Scientific Quality & Translational Potential

Your research must be basic or translational (lab-based or connected to clinical trials) in hematology—not purely clinical or health economics .

Innovation Grants require high‑risk, high‑gain objectives with clear deliverables leading to larger EU funding .

👥 4. Team Composition & Peer Review Strength

Innovation Grants must include a strong multinational team (≥3 PIs) with demonstrated complementary expertise .

Review panels judge both project merit (significance, novelty, methods, environment, feasibility) and investigator strength (track record, collaboration ability) .

📊 5. Budget Realism & Timeline Matching

Budgets must be clearly itemized, justified, and matched to the proposed timeline .

🕰️ 6. Structured, Multi-Stage Review & Interviews

After eligibility checks and internal screening, applications undergo expert external peer reviews (≥3), with top candidates invited to interviews (Innovation Grants: scored by Committee; Research Grants: video interviews ~25 min) .

🔧 7. Administrative Rigor & Reporting Obligations

Omission of required attachments (budget, mentor/institution letters) leads to rejection .

Successful applicants enter grant agreements, submit interim/final scientific + audited financial reports, acknowledge EHA funding in publications, and use Researchfish for tracking impact

✅ Summary Table

Success Predictor	What to Demonstrate
EHA Membership & Endorsement	Active membership, institutional buy-in
Correct Scheme Selection	Match grant to your career level and project type
Scientific Innovation	Novel, basic/translational hematology research
Strong Collaborative Team	Multinational consortia and mentorship
Solid Proposal & Budget	Rigorous methods, realistic budget & timeline
Alignment with Review Criteria	Significance, originality, feasibility, investigator merit
Reporting & Compliance	Complete paperwork; commit to reporting & fundraising impact

🛠️ Strategic Tips

Confirm membership and start early on recommendation letters and grant documentation.

Pick the right funding route (Junior/Advanced/Innovation) based on your stage and project scope.

Design your project for translation, aiming to leverage future opportunities like Horizon Europe.

Build your consortium wisely, especially for Innovation Grants (≥3 European PIs).

Craft your budget and timeline meticulously—align each cost with project aims.

Prepare thoroughly for interviews, summarizing your project clearly in 10 minutes.

Organize grant administration with your institution ahead of time, anticipating reports and impact tracking.

Specialties

Hematology

Eligibility Requirements

General criteria for the EHA Research Grant

You’re eligible if:

You’re an EHA member
Your institute is an academic research center or proven equivalent in Europe
You have the support of an academic department and institute
Your application relates to basic and translational lab-based research in hematology

Your application will not be eligible if it relates to:

Purely clinical research projects
Projects in health economics
Other non-lab-based research

However, it may be eligible if it relates to the translational part of a clinical trial. In this case, it must be both relevant and novel.

Sponsor Details

Sponsor Institute/Organizations: European Hematology Association

Sponsor Type: Corporate/Non-Profit

Address: Koninginnegracht 12b 2514 AA The Hague The Netherlands Phone: +31 (0)70 3020 099 Email: info@ehaweb.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity